A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
Authors:
Open Access
- 18 November 2025
- journal article
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (11) , 102452
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2022YFC2409501)
- National Key Research and Development Program of China (2022YFC2502600)
- Shanghai Municipal Hospital Development Center (SHDC2020CR1032B)
- Shanghai Municipal Hospital Development Center (SHDC2022CRD033)
- National Natural Science Foundation of China (82300210)
- National Natural Science Foundation of China (82200200)
- National Natural Science Foundation of China (82370187)
- National Natural Science Foundation of China (82472065)
- National Natural Science Foundation of China (82570234)
- National Natural Science Foundation of China (82200201)
- National Natural Science Foundation of China (W2432049)
- National Natural Science Foundation of China (82200199)
- National Natural Science Foundation of China (82130004)
- Changjiang Scholar Program, Ministry of Education
- Sichuan University
- Natural Science Foundation of Sichuan Province (2024NSFSC1701)
- Shanghai Municipal Education Commission (20152206)
- Shanghai Municipal Education Commission (20152208)
- Shanghai Municipal Education Commission (20230013)
- Shanghai Municipal Education Commission (20220018)
- West China Hospital of Sichuan University (ZYAI24039)
- School of Medicine, Shanghai Jiao Tong University (DLY201601)
This publication has 49 references indexed in Scilit:
- Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trialCancer Cell, 2023
- The evolving therapy of DLBCL: Bispecific antibodiesHematological Oncology, 2023
- Deep learning–based tumour segmentation and total metabolic tumour volume prediction in the prognosis of diffuse large B-cell lymphoma patients in 3D FDG-PET imagesEuropean Radiology, 2022
- Clinical efficacy and tumour microenvironment influence of decitabine plus R‐CHOP in patients with newly diagnosed diffuse large B‐Cell lymphoma: Phase 1/2 and biomarker studyClinical and Translational Medicine, 2021
- The landscape of tumor cell states and ecosystems in diffuse large B cell lymphomaCancer Cell, 2021
- Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.European Journal of Nuclear Medicine and Molecular Imaging, 2020
- A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsCancer Cell, 2020
- Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomicsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2014
- User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliabilityNeuroImage, 2006